(Q37073708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

Hepatitis C genotype 4: What we know and what we don't yet know (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Imad A Nasser

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

1371-1383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18240152%20AND%20SRC:MED&resulttype=core&format=json

Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East.

2 January 2020

cites work

1 reference

The origin of hepatitis C virus genotypes.

21 January 2018

1 reference

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

21 January 2018

1 reference

Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha

21 January 2018

1 reference

Optimized virologic response in hepatitis C virus genotype 4 with peginterferon-alpha2a and ribavirin

21 January 2018

1 reference

Treatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage

21 January 2018

1 reference

Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center

21 January 2018

1 reference

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy

21 January 2018

1 reference

7 January 2021

Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

1 reference

7 January 2021

Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence

1 reference

7 January 2021

Molecular heterogeneity and new subtypes of HCV genotype 4.

1 reference

7 January 2021

Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

1 reference

7 January 2021

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

7 January 2021

Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

1 reference

7 January 2021

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

1 reference

7 January 2021

Characterization of full-length hepatitis C virus genotype 4 sequences.

1 reference

7 January 2021

Genetic diversity and evolution of hepatitis C virus--15 years on

1 reference

7 January 2021

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.

1 reference

7 January 2021

Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma

1 reference

7 January 2021

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

1 reference

7 January 2021

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

7 January 2021

Molecular epidemiology of hepatitis C virus genotype 4 isolates in Egypt and analysis of the variability of envelope proteins E1 and E2 in patients with chronic hepatitis

1 reference

7 January 2021

Genetic epidemiology of hepatitis C virus throughout egypt

1 reference

7 January 2021

Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon).

1 reference

7 January 2021

Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon

1 reference

7 January 2021

The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960.

1 reference

7 January 2021

The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach

1 reference

7 January 2021

Exponential spread of hepatitis C virus genotype 4a in Egypt

1 reference

7 January 2021

Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections

1 reference

7 January 2021

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

1 reference

7 January 2021

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni

1 reference

7 January 2021

Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity

1 reference

7 January 2021

Changing patterns of acute viral hepatitis at a major urban referral center in Egypt

1 reference

7 January 2021

Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women

1 reference

7 January 2021

Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt

1 reference

7 January 2021

Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients

1 reference

7 January 2021

Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data

1 reference

7 January 2021

Intrafamilial transmission of hepatitis C in Egypt

1 reference

7 January 2021

Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study.

1 reference

7 January 2021

Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France

1 reference

7 January 2021

Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.

1 reference

7 January 2021

Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.

1 reference

7 January 2021

High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses

1 reference

7 January 2021

Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1.

1 reference

7 January 2021

Infection with hepatitis C virus genotype 4 in the United States

1 reference

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

7 January 2021

Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features

1 reference

7 January 2021

HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.

1 reference

7 January 2021

Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?

1 reference

7 January 2021

Duration of peginterferon therapy in acute hepatitis C: a randomized trial

1 reference

7 January 2021

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.

1 reference

7 January 2021

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

1 reference

7 January 2021

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

1 reference

7 January 2021

Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004.

1 reference

7 January 2021

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

1 reference

7 January 2021

Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis

1 reference

7 January 2021

Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.

1 reference

7 January 2021

Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases

1 reference

7 January 2021

Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors

1 reference

7 January 2021

Non-alcoholic fatty liver disease in patients with HCV genotype 4

1 reference

7 January 2021

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response.

1 reference

7 January 2021

Hepatitis C and steatosis: a reappraisal

1 reference

7 January 2021

Steatosis and chronic hepatitis C virus infection: mechanisms and significance.

1 reference

7 January 2021

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

7 January 2021

Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection

1 reference

7 January 2021

Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study

1 reference

7 January 2021

Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt.

1 reference

7 January 2021

The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation

1 reference

7 January 2021

Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation

1 reference

7 January 2021

Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution

1 reference

7 January 2021

Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4

1 reference

7 January 2021

Interferon therapy in patients with chronic hepatitis C and schistosomiasis

1 reference

7 January 2021

Improved response to ribavirin interferon combination compared with interferon alone in patients with type 4 chronic hepatitis C without cirrhosis

1 reference

7 January 2021

Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4.

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4.

1 reference

7 January 2021

Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4.

1 reference

7 January 2021

Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response.

1 reference

7 January 2021

Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study

1 reference

7 January 2021

Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection

1 reference

7 January 2021

Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis.

1 reference

7 January 2021

A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C.

1 reference

7 January 2021

Financial impact of two different ways of evaluating early virological response to peginterferon-alpha-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1.

1 reference

7 January 2021

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia

1 reference

7 January 2021